DownloadGiuseppe Berton, MD, FESC, Rocco Cordiano, MD, Rosa Palmieri, MD, Sigismondo Pianca, MD, Valeria Pagliara, MD, and Paolo Palatini, MD Padua, Italy
Background High C-reactive protein (CRP) levels have been associated with higher mortality rate in patients withacute myocardial infarction (AMI). However, it is not known whether inflammation plays a role in the time-course of heartfailure (HF) in this clinical setting. Our aim was to study the nature of the relationship between CRP and HF during AMI.
Methods This prospective study was carried out in 269 subjects admitted to the hospital for suspected AMI. Ofthese, 220 had evidence of AMI. The other 49 subjects were studied as controls. CRP was assessed on the first, third,and seventh day after admission.
Results CRP was significantly higher in the patients with AMI than in the control patients (P.001) and peaked onthe third day. Among the patients with AMI, CRP was higher in patients with HF than in patients without HF (adjustedP.008,P.02 andP.03 on 1st, 3rd, and 7th day, respectively). Prevalence of HF on admission was slightly higher inthe subjects with first-day CRP15 mg/L than in those with CRP15 mg/L, and the between-group difference progres-sively increased from the first to the seventh day (P.0001). At multivariable regression analysis, first-day log-CRP wasshown to be a strong independent predictor of both HF progression (P.0001) and left ventricular ejection fraction (P.0001). One-year total mortality and HF-mortality rates turned out to be higher in the patients with CRP85 mg/L than inthose with CRP below that level (P.0001), and log–third-day CRP was independently associated with 1-year mortalityat multivariable analysis (P.0001).
Conclusions CRP on admission to hospital is suitable for predicting the time-course of HF in patients with AMI. Peak CRP value is a strong independent predictor of global and HF-mortality during the following year.
(Am Heart J2003;145:1094-101.)
